EW - Edwards Lifesciences Corporation
| Previous Close | 242.96 |
| Open | 245.00 |
| Bid | 0.00 x 800 |
| Ask | 269.85 x 900 |
| Day's Range | 238.78 - 245.99 |
| 52 Week Range | 139.64 - 247.64 |
| Volume | 2,837,845 |
| Avg. Volume | 1,118,504 |
| Market Cap | 49.844B |
| Beta (3Y Monthly) | 0.80 |
| PE Ratio (TTM) | 65.62 |
| EPS (TTM) | 3.64 |
| Earnings Date | Jan. 29, 2020 - Feb. 3, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 250.21 |
- Zacks
NuVasive (NUVA) Hits 52-Week High, Can the Run Continue?
NuVasive (NUVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- Zacks
Here's Why You Should Retain Nevro (NVRO) Stock for Now
Nevro (NVRO) is gaining traction from strengthening international footprint and solid prospects in the SCS market. However, stiff competition remains a woe.
- Zacks
Cooper Companies (COO) Q4 Earnings Beat, Revenues Rise Y/Y
Cooper (COO) gains from solid segmental contributions in fiscal fourth quarter.
- Zacks
Patterson Companies (PDCO) Q2 Earnings Surpass Estimates
Patterson Companies' (PDCO) Q2 results benefit from higher revenues, gross margin expansion and solid show by Dental segment.
- Simply Wall St.
Here's Why I Think Edwards Lifesciences (NYSE:EW) Might Deserve Your Attention Today
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
- Zacks
What's in the Cards for Cantel Medical (CMD) in Q1 Earnings?
Better-than-expected performance at both Medical and Dental segments is likely to have driven Cantel Medical (CMD) in Q1 earnings.
- Zacks
Here's Why You Should Hold On to HMS Holdings (HMSY) Stock
HMS Holdings (HMSY) is gaining traction from growing PI and TPM analytical services. However, high debt continues to raise concerns.
- Zacks
Cooper Companies (COO) to Post Q4 Earnings: What's in Store?
Better-than-expected performance at CVI and CSI, and higher revenues are likely to have aided Cooper Companies (COO) in Q4 earnings.
- Zacks
Edwards Lifesciences (EW) Up 6.1% Since Last Earnings Report: Can It Continue?
Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks
What's in the Cards for Veeva Systems (VEEV) in Q3 Earnings?
Robust product portfolio and higher revenues are likely to have benefited Veeva Systems (VEEV) in third-quarter fiscal 2020 earnings.
- Zacks
Edwards Lifesciences, Fossil, United Airlines and Boeing highlighted as Zacks Bull and Bear of the Day
Edwards Lifesciences, Fossil, United Airlines and Boeing highlighted as Zacks Bull and Bear of the Day
- Zacks
Edwards Lifesciences (EW) Recalls PASCAL's Guide Sheath
Edwards Lifesciences (EW) issues a product recall for its guide sheath based on report from its urgent field safety notice.
- Zacks
Top & Flop ETFs of Last Week
Cocoa ETF was a hot trade last week while cannabis ETF lost the most.
- Zacks
Haemonetics (HAE) Grows on New Products, Robust Plasma Sales
Haemonetics (HAE) witnesses a steady uptick in Plasma franchise, fueled by favorable price, volume and mix.
- Simply Wall St.
A Close Look At Edwards Lifesciences Corporation’s (NYSE:EW) 23% ROCE
Today we'll evaluate Edwards Lifesciences Corporation (NYSE:EW) to determine whether it could have potential as an...
- Zacks
Will Edwards Lifesciences (EW) Gain on Rising Earnings Estimates?
Edwards Lifesciences (EW) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
- Zacks
Is Edwards Lifesciences (EW) a Solid Growth Stock? 3 Reasons to Think " Yes "
Edwards Lifesciences (EW) is well positioned to outperform the market, as it exhibits above-average growth in financials.
- Zacks
Penumbra's (PEN) Q3 Earnings & Revenues Surpass Estimates
Penumbra (PEN) witnessed strong growth across all geographies and product lines in Q3.
- Zacks
Dentsply (XRAY) Soars to 52-Week High, Time to Cash Out?
Dentsply (XRAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- Zacks
Nevro (NVRO) Q3 Loss Narrower Than Expected, Revenues Up Y/Y
Nevro (NVRO) launches the Senza Omnia SCS System commercially in the United States in Q3.
- Zacks
DexCom (DXCM) Earnings and Revenues Beat Estimates in Q3
DexCom's (DXCM) Q3 earnings benefit from higher revenues, solid performing Sensor and Transmitter segments and strong 2019 outlook. However, contraction in gross margin remains a woe.
- Zacks
Glaukos (GKOS) Q3 Loss Narrower Than Expected, '19 View Up
Glaukos' (GKOS) Q3 revenues surge year over year. Also, the company raises 2019 revenue guidance.
- Investor's Business Daily Video
Analyzing Top ESG Stocks Microsoft, Edwards Lifesciences
Finding top-performing stocks doesn't have to mean a tradeoff with environmental, social and governance values. Microsoft and Edwards Lifesciences are two top stocks that made IBD's just-released ESG 50 list. Their strong fundamentals and ESG initiatives show up in the chart action.
